CGL
ZY

Clarius Group LLC’s Zymergen Inc. Common Stock ZY Stock Holding History

Clarius Group LLC’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,350
Closed -$54K – 543
2022
Q3 		$54K Hold
19,350
– – 0.01% 485
2022
Q2 		$24K Hold
19,350
– – ﹤0.01% 468
2022
Q1 		$129K Hold
19,350
– – 0.01% 483
2021
Q4 		$129K Sell
19,350
-470
-2% -$4.56K 0.01% 483
2021
Q3 		$261K Buy
+19,820
New +$421K 0.02% 348

Clarius Group LLC's ZY Position: Q4 2022 in Review

Clarius Group LLC sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 19,350 shares — an estimated $54K sold.

Clarius Group LLC first reported a position in ZY in Q3 2021 and held it in 5 quarters. The position peaked at $261K in Q3 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Clarius Group LLC reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clarius Group LLC sold 19,350 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $54K.
  • Clarius Group LLC first reported a position in Zymergen Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Clarius Group LLC's Zymergen Inc. Common Stock position peaked at $261K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Clarius Group LLC's 13F filing for Q4 2022, filed 25 Jan 2023.